中文名 | DL-蛋氨醇 |
---|---|
英文名 | dl-methioninol |
中文别名 | D-蛋氨醇 |
英文别名 |
2-Amino-4-(methylthio)-1-butanol
D-methioninol MFCD00068312 DL-METHIONOL 2-amino-4-(methylthio)butan-1-ol 2-amino-4-(methylsulfanyl)butan-1-ol 2-azanyl-4-methylsulfanyl-butan-1-ol 1-Butanol, 2-amino-4-(methylthio)- methioninol DL-Methioninol DL-Methioninol2-Amino-4-(methylthio)-1-butanol 4-METHYLMERCAPTO-2-AMINO-1-BUTANOL L-2-amino-4-methylsulfanylbutanol 2-amino-4-methylthio-1-butanol 2-Amino-4-(methylsulfanyl)-1-butanol (+-)-2-Amino-4-methylmercapto-butan-1-ol H-DL-MET-OL (+-)-2-amino-4-methylsulfanyl-butan-1-ol |
密度 | 1.1±0.1 g/cm3 |
---|---|
沸点 | 270.2±30.0 °C at 760 mmHg |
熔点 | 31-36 °C |
分子式 | C5H13NOS |
分子量 | 135.228 |
闪点 | 117.2±24.6 °C |
精确质量 | 135.071777 |
PSA | 71.55000 |
LogP | -0.11 |
外观性状 | viscous liquid |
蒸汽压 | 0.0±1.2 mmHg at 25°C |
折射率 | 1.516 |
储存条件 | 密封储存,储存于阴凉、干燥的库房。 |
稳定性 | 避免与不相容材料接触。与强氧化剂反应。 |
计算化学 | 1.疏水参数计算参考值(XlogP):-0.3 2.氢键供体数量:2 3.氢键受体数量:3 4.可旋转化学键数量:4 5.互变异构体数量:无 6.拓扑分子极性表面积71.6 7.重原子数量:8 8.表面电荷:0 9.复杂度:51.7 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:1 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
更多 | 1. 性状:黄色透明液体 2. 密度(g/mL,25℃):未确定 3. 相对蒸汽密度(g/mL,空气=1):未确定 4. 熔点(ºC):31-36 5. 沸点(ºC,常压):未确定 6. 沸点(ºC,1mmHg):未确定 7. 折射率(n20/D):1.519-1.521(lit.) 8. 闪点(ºF):未确定 9. 比旋光度(º):未确定 10. 自燃点或引燃温度(ºC):未确定 11. 蒸气压(mmHg,25ºC):未确定 12. 饱和蒸气压(kPa,25ºC):未确定 13. 燃烧热(KJ/mol):未确定 14. 临界温度(ºC):未确定 15. 临界压力(KPa):未确定 16. 油水(辛醇/水)分配系数的对数值:未确定 17. 爆炸上限(%,V/V):未确定 18. 爆炸下限(%,V/V):未确定 19. 溶解性:溶于水 |
Synonym:2-Amino-4-(methylthio)-1-butano Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
Risk Phrases: 36/37/38 Section 3 - HAZARDS IDENTIFICATION EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin. Potential Health Effects Eye: Causes eye irritation. Skin: Causes skin irritation. May be harmful if absorbed through the skin. Ingestion: May cause irritation of the digestive tract. May be harmful if swallowed. Inhalation: Causes respiratory tract irritation. May be harmful if inhaled. Chronic: Not available. Section 4 - FIRST AID MEASURES Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid. Skin: Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Ingestion: Get medical aid. Wash mouth out with water. Inhalation: Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Notes to Physician: Treat symptomatically and supportively. Section 5 - FIRE FIGHTING MEASURES General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Extinguishing Media: Use water spray, dry chemical, carbon dioxide, or chemical foam. Section 6 - ACCIDENTAL RELEASE MEASURES General Information: Use proper personal protective equipment as indicated in Section 8. Spills/Leaks: Vacuum or sweep up material and place into a suitable disposal container. Section 7 - HANDLING and STORAGE Handling: Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes. Storage: Store in a tightly closed container. Store in a dry area. Keep refrigerated. (Store below 4C/39F.) Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION Engineering Controls: Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low. Exposure Limits CAS# 502-83-0: Personal Protective Equipment Eyes: Not available. Skin: Wear appropriate protective gloves to prevent skin exposure. Clothing: Wear appropriate protective clothing to prevent skin exposure. Respirators: Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced. Section 9 - PHYSICAL AND CHEMICAL PROPERTIES Physical State: Solid Color: Not available. Odor: Not available. pH: Not available. Vapor Pressure: Not available. Viscosity: Not available. Boiling Point: Not available. Freezing/Melting Point: 31 - 36 deg C Autoignition Temperature: Not available. Flash Point: Not available. Explosion Limits, lower: Not available. Explosion Limits, upper: Not available. Decomposition Temperature: Solubility in water: Soluble. Specific Gravity/Density: Molecular Formula: C5H13NOS Molecular Weight: 135.23 Section 10 - STABILITY AND REACTIVITY Chemical Stability: Not available. Conditions to Avoid: Incompatible materials. Incompatibilities with Other Materials: Strong oxidizing agents. Hazardous Decomposition Products: Nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide. Hazardous Polymerization: Not available. Section 11 - TOXICOLOGICAL INFORMATION RTECS#: CAS# 502-83-0 unlisted. LD50/LC50: Not available. Carcinogenicity: DL-Methioninol - Not listed by ACGIH, IARC, or NTP. Section 12 - ECOLOGICAL INFORMATION Section 13 - DISPOSAL CONSIDERATIONS Dispose of in a manner consistent with federal, state, and local regulations. Section 14 - TRANSPORT INFORMATION IATA Not regulated as a hazardous material. IMO Not regulated as a hazardous material. RID/ADR Not regulated as a hazardous material. Section 15 - REGULATORY INFORMATION European/International Regulations European Labeling in Accordance with EC Directives Hazard Symbols: XI Risk Phrases: R 36/37/38 Irritating to eyes, respiratory system and skin. Safety Phrases: S 26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S 37/39 Wear suitable gloves and eye/face protection. WGK (Water Danger/Protection) CAS# 502-83-0: No information available. Canada None of the chemicals in this product are listed on the DSL/NDSL list. CAS# 502-83-0 is not listed on Canada's Ingredient Disclosure List. US FEDERAL TSCA CAS# 502-83-0 is not listed on the TSCA inventory. It is for research and development use only. SECTION 16 - ADDITIONAL INFORMATION N/A |
危害码 (欧洲) | Xi |
---|---|
风险声明 (欧洲) | 36/37/38 |
安全声明 (欧洲) | S37/39-S26 |
WGK德国 | 3 |
~91% 502-83-0 |
文献:Ashton; Aumann, Kylee M.; Baker, Stephen P.; Schiesser, Carl H.; Scammells, Peter J. Bioorganic and Medicinal Chemistry Letters, 2007 , vol. 17, # 24 p. 6779 - 6784 |
~% 502-83-0 |
文献:Ohfune, Yasufumi; Kurokawa, Natsuko Tetrahedron Letters, 1984 , vol. 25, # 10 p. 1071 - 1074 |
~% 502-83-0 |
文献:Ohfune, Yasufumi; Kurokawa, Natsuko Tetrahedron Letters, 1984 , vol. 25, # 10 p. 1071 - 1074 |
~% 502-83-0 |
文献:Ohfune, Yasufumi; Kurokawa, Natsuko Tetrahedron Letters, 1984 , vol. 25, # 10 p. 1071 - 1074 |
~% 502-83-0 |
文献:Gebhard; Karrer Helvetica Chimica Acta, 1955 , vol. 38, p. 915 |
上游产品 5 | |
---|---|
下游产品 2 | |